Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.95%1.15T | 6.29%4.68T | 12.21%1.12T | 9.92%4.4T | 7.98%1.18T | 12.63%1.15T | 6.31%1.08T | 13.34%994.12B | 18.93%4.01T | 17.75%1.09T |
| Cost of revenue | 1.81%941.52B | 4.52%3.8T | 8.87%924.77B | 8.98%3.64T | 8.03%955.95B | 9.70%934.39B | 4.20%895.46B | 14.85%849.43B | 19.39%3.34T | 15.01%884.9B |
| Gross profit | 8.46%206.92B | 14.66%880.13B | 31.85%190.78B | 14.57%767.59B | 7.79%224.94B | 27.37%215.43B | 18.07%182.52B | 5.19%144.7B | 16.73%669.98B | 30.99%208.69B |
| Operating expense | 6.64%146.62B | 3.42%559.46B | 9.33%137.49B | 9.83%540.97B | 16.32%146.65B | 8.36%134.43B | 8.30%134.13B | 6.08%125.76B | 9.03%492.53B | 10.96%126.07B |
| Operating profit | 13.17%60.3B | 41.50%320.66B | 181.40%53.29B | 27.71%226.62B | -5.24%78.29B | 79.66%81B | 57.44%48.39B | -0.34%18.94B | 45.21%177.44B | 80.79%82.62B |
| Net non-operating interest income (expenses) | 28.24%-5.15B | 1.97%-26.01B | -16.44%-7.18B | -82.02%-26.53B | -32.70%-7.03B | -59.13%-6.73B | -109.13%-6.6B | -226.18%-6.17B | -221.23%-14.57B | -361.67%-5.3B |
| Non-operating interest income | 5.79%859M | 34.00%3.74B | 58.59%812M | 82.26%2.79B | 81.78%958M | 61.01%702M | 104.61%622M | 92.48%512M | 50.00%1.53B | 77.44%527M |
| Non-operating interest expense | -24.78%6.01B | 1.46%29.75B | 19.67%7.99B | 82.04%29.32B | 37.14%7.99B | 59.31%7.43B | 108.73%7.22B | 209.69%6.68B | 189.75%16.11B | 303.25%5.83B |
| Net investment income | -4.20%3.19B | 25.71%8.22B | 34.27%3.33B | 68.76%6.54B | 303.55%802M | 20.69%1.62B | 180.34%1.64B | 5.84%2.48B | -4.48%3.88B | -245.93%-394M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -83.41%11.09B | 105.78%66.83B | 171.45%63.33B | 197.46%1.05B | 33.90%2.45B | 0 | 190.14%32.48B | 108.42%23.33B | ||
| Income from associates and other participating interests | -65.06%3.15B | -26.77%14.78B | 204.49%9.02B | 75.68%20.18B | 571.30%5.63B | 196.98%8.16B | -22.46%3.43B | -46.30%2.96B | -64.21%11.49B | -107.36%-1.2B |
| Special income (charges) | -23.64%-638M | 62.14%-16.52B | 12.10%-516M | -236.16%-43.63B | -231.27%-35.63B | -215.96%-1.32B | -107.95%-6.1B | -38.12%-587M | -238.35%-12.98B | -61.36%-10.76B |
| Less:Restructuring and mergern&acquisition | ---- | 41.36%22.07B | ---- | 62.26%15.61B | 125.67%9.57B | 4.50%580M | ---- | ---- | 78.02%9.62B | -21.52%4.24B |
| Less:Other special charges | 23.64%638M | -157.85%-10.76B | -12.10%516M | 3,382.40%18.6B | 350.75%16.64B | 143.52%735M | 133.65%637M | 38.12%587M | 106.65%534M | 171.05%3.69B |
| Less:Write off | ---- | -44.76%5.2B | ---- | 233.72%9.42B | ---- | ---- | ---- | ---- | -56.27%2.82B | ---- |
| Other non-operating income (expenses) | 2.37%345M | 28.84%-8.16B | 131.64%337M | -812.33%-11.47B | -1,283.44%-1.79B | -13.59%-5.37B | -280.70%-3.25B | -170.11%-1.07B | -0.88%-1.26B | 287.18%151M |
| Income before tax | 5.01%61.2B | 27.47%304.06B | 251.89%58.28B | 21.41%238.55B | 17.12%103.6B | 88.03%78.42B | 20.08%39.96B | -49.86%16.56B | 22.86%196.47B | 34.81%88.46B |
| Income tax | -3.59%20.26B | 18.19%82.24B | 76.61%21.02B | 8.39%69.58B | 35.04%26.91B | 21.50%20.49B | -24.57%10.29B | -13.59%11.9B | 27.84%64.2B | 32.85%19.93B |
| Net income | 9.87%40.94B | 31.29%221.83B | 699.42%37.26B | 27.74%168.96B | 11.91%76.7B | 133.19%57.93B | 51.08%29.68B | -75.80%4.66B | 20.57%132.27B | 35.39%68.53B |
| Net income continuous operations | 9.87%40.94B | 31.29%221.83B | 699.42%37.26B | 27.74%168.96B | 11.91%76.7B | 133.19%57.93B | 51.08%29.68B | -75.80%4.66B | 20.57%132.27B | 35.39%68.53B |
| Noncontrolling interests | 5.82%5.82B | 45.83%28.06B | 101.17%5.5B | -1.94%19.24B | -63.57%4.16B | 70.63%7.43B | 0.84%4.91B | 364.06%2.73B | 46.45%19.62B | 92.68%11.43B |
| Net income attributable to the company | 10.57%35.12B | 29.42%193.77B | 1,547.46%31.76B | 32.91%149.72B | 27.02%72.53B | 146.49%50.5B | 67.63%24.77B | -90.50%1.93B | 16.98%112.65B | 27.79%57.1B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 10.57%35.12B | 29.42%193.77B | 1,547.46%31.76B | 32.91%149.72B | 27.02%72.53B | 146.49%50.5B | 67.63%24.77B | -90.50%1.93B | 16.98%112.65B | 27.79%57.1B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 10.56%45.03 | 29.42%248.47 | 1,548.99%40.73 | 32.90%191.98 | 27.01%93 | 146.57%64.75 | 67.60%31.76 | -90.51%2.47 | 16.97%144.45 | 27.78%73.22 |
| Diluted earnings per share | 10.56%45.03 | 29.42%248.47 | 1,548.99%40.73 | 32.90%191.98 | 27.02%93 | 146.57%64.7495 | 67.64%31.759 | -90.51%2.47 | 16.97%144.45 | 27.79%73.2171 |
| Dividend per share | 0 | 25.97%97 | 0 | 54.00%77 | 108.00%52 | 0 | 0.00%25 | 0 | 0.00%50 | 0.00%25 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |